Knockdown of liver-derived factor XII by GalNAc-siRNA ALN-F12 prevents thrombosis in mice without impacting hemostatic function - Oligonucleotide Therapeutics Society

Knockdown of liver-derived factor XII by GalNAc-siRNA ALN-F12 prevents thrombosis in mice without impacting hemostatic function

AUTHOR

OTS

DATE

October 13, 2020

CATEGORIES

Ago/siRNA/saRNA

SHARE

Post Views: 354

Liu J, Cooley BC, Akinc A, Butler J, Borodovsky A.

Thromb Res. 2020 Aug 28;196:200-205.

Related articles

Subscribe to our Newsletter

OTS_Logo_retina

Oligonucleotide Therapeutics Society

c/o Event Innovations, Inc.
4377 Newport Avenue
San Diego, CA 92107, USA

(619) 795-9458
info@oligotherapeutics.org

Resources

Stay Connected

Search

Subscribe in a reader

© Copyright 2012 – 2022 | Oligotherapeutics.org | All Rights Reserved | Finfrock Marketing

Username/Email Address:
Password:
Forgot Password? | Sign Up

Save Password

First Name *
Last Name *
Username *
Email *
Password *
Confirm Password *
Phone:
Organization Name
Select Sectors
By clicking checkbox, you agree to our Terms and Conditions and Privacy Policy

Already have an account? Login